| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mural Oncology plc | Chief Financial Officer | Stock Option (right to buy) | 0 | $217,750 | $3.35 | 05 Dec 2025 | Direct |
| Mural Oncology plc | Chief Financial Officer | Ordinary Shares | 0 | $0 | $2.07 | 05 Dec 2025 | Direct |
| InMed Pharmaceuticals Inc. | Director | Employee Stock Option (Expiration) | 16,122 | 24 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MURA | Mural Oncology plc | 05 Dec 2025 | 3 | $0 | 4 | Chief Financial Officer | 05 Dec 2025, 08:43 |
| MURA | Mural Oncology plc | 03 Nov 2025 | 1 | -$14,939 | 4 | Chief Financial Officer | 10 Nov 2025, 18:30 |
| MURA | Mural Oncology plc | 03 Mar 2025 | 2 | $0 | 4 | Chief Financial Officer | 05 Mar 2025, 16:47 |
| MURA | Mural Oncology plc | 31 Oct 2024 | 1 | -$25,306 | 4 | Chief Financial Officer | 01 Nov 2024, 07:04 |
| MURA | Mural Oncology plc | 14 Dec 2023 | 2 | $0 | 4 | Chief Financial Officer | 18 Dec 2023, 16:30 |
| MURA | Mural Oncology plc | 15 Nov 2023 | 0 | $0 | 3 | Chief Financial Officer | 15 Nov 2023, 16:01 |
| INM | InMed Pharmaceuticals Inc. | 24 Jan 2022 | 3 | $0 | 4 | Director | 24 Jan 2022, 15:17 |
| INM | InMed Pharmaceuticals Inc. | 29 Dec 2021 | 1 | $0 | 4 | Director | 30 Dec 2021, 17:00 |